ARHGEF2 and adenocarcinoma: Expression of ARHGEF2 was also significantly increased in neuroendocrine differentiation CRPC (CRPC-NE) samples compared to CRPC with adenocarcinoma characteristics (CRPC-Adeno) samples (Fig. 1B).